Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multinucleated giant cells in human pancreatic cancer are a distinct macrophage population undergoing a DNA damage response and associated with an aggressive tumor microenvironment.

Cancer immunology research·2026
Same author

"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?"

European journal of cancer (Oxford, England : 1990)·2026
Same author

Extended Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients.

JAMA network open·2026
Same author

IL1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma.

Cancer immunology research·2026
Same author

Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching.

Tumori·2025

Related Experiment Video

Updated: Aug 9, 2025

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
07:47

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis

Published on: June 26, 2016

9.8K

Macrophages and bone metastasis.

Diletta Di Mitri1,2, Fabio Conforti3, Alberto Mantovani4,5

  • 1Department of Biomedical Sciences, Humanitas University , Pieve Emanuele, Italy.

The Journal of Experimental Medicine
|February 24, 2023
PubMed
Summary
This summary is machine-generated.

Macrophages in prostate cancer bone metastasis create a pathway involving Activin A, extracellular matrix, and SRC kinase. This cascade drives resistance to anti-androgen therapy, impacting hormone and immunity interactions.

More Related Videos

Bone Marrow-derived Macrophage Production
07:06

Bone Marrow-derived Macrophage Production

Published on: November 22, 2013

73.7K
Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.2K

Related Experiment Videos

Last Updated: Aug 9, 2025

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
07:47

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis

Published on: June 26, 2016

9.8K
Bone Marrow-derived Macrophage Production
07:06

Bone Marrow-derived Macrophage Production

Published on: November 22, 2013

73.7K
Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.2K

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Prostate cancer bone metastasis is a complex microenvironment.
  • Therapy resistance is a major clinical challenge in advanced prostate cancer.
  • The interplay between the immune system and cancer cells is crucial for tumor progression.

Purpose of the Study:

  • To elucidate the molecular mechanisms driving resistance to anti-androgen therapy in prostate bone metastasis.
  • To identify key cellular and molecular players within the bone metastasis microenvironment.

Main Methods:

  • Investigated the role of macrophages in the prostate bone metastasis microenvironment.
  • Analyzed the signaling cascade involving Activin A, extracellular matrix, and SRC kinase.
  • Assessed the impact of this cascade on anti-androgen therapy resistance.

Main Results:

  • Macrophages activate a cascade involving Activin A, extracellular matrix, and SRC kinase.
  • This cascade promotes resistance to anti-androgen therapy in prostate cancer bone metastasis.
  • Findings highlight the heterogeneity of metastasis in different tissue environments.

Conclusions:

  • The identified pathway is a critical driver of treatment resistance in prostate cancer bone metastasis.
  • Understanding this interplay between hormones and immunity offers new therapeutic targets.
  • Metastasis diversity is influenced by tissue-specific microenvironmental factors.